CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
1. CorMedix will report Q4 earnings on March 25. 2. Analysts forecast earnings at 14 cents per share. 3. CorMedix projects revenue of $28.34 million. 4. Recent promotions for DefenCath® target VA facilities. 5. Analysts have raised CRMD price targets recently.